Cyclodextrin–poloxamer aggregates as nanocarriers in eye drop formulations: dexamethasone and amphotericin B

References

• Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 1996;85:1017–25.
   PubMed Web of Science ®Google Scholar
• Uekama K, Hirayama F, Irie T. Cyclodextrin drug carrier systems. Chem Rev 1998;98:2045–76.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Stefánsson E. Cyclodextrins in ocular drug delivery: theoretical basis with dexamethasone as a sample drug. J Drug Deliv Sci Technol 2007;17:3–9.
   Web of Science ®Google Scholar
• Loftsson T, Friðriksdóttir H, Sigurðardóttir AM, Ueda H. The effect of water-soluble polymers on drug-cyclodextrin complexation. Int J Pharm 1994;110:169–77.
   Web of Science ®Google Scholar
• Savolainen J, Järvinen K, Taipale H, et al. Co-administration of a water-soluble polymer increases the usefulness of cyclodextrins in solid oral dosage forms. Pharm Res 1998;15:1696–701.
   PubMed Web of Science ®Google Scholar
• Munro IC, Newberne PM, Young VR, Bär A. Safety assessment of γ-cyclodextrin. Regul Toxicol Pharmacol 2004;39:S3–S13.
   PubMed Web of Science ®Google Scholar
• Koutsou GA, Storey DM, Bär A. Gastrointestinal tolerance of gamma-cyclodextrin in humans. cyclodextrin humans. Food Addit Contam 1999;16:313–7.
   PubMed Web of Science ®Google Scholar
• Ohtani Y, Irie T, Uekama K, et al. Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes. Eur J Biochem 1989;186:17–22.
   PubMedGoogle Scholar
• Mahmoud AA, El-Feky GS, Kamel R, Awad GEA. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery. Int J Pharm 2011;413:229–36.
   PubMed Web of Science ®Google Scholar
• Fülöp Z, Balogh A, Saokham P, et al. Formation and stability assessment of self-assembled nanoparticles from large Mw chitosan and sulfobutylether-β-cyclodextrin. J Drug Deliv Sci Technol 2015;30:478–85.
   Web of Science ®Google Scholar
• Moya-Ortega MD, Alvarez-Lorenzo C, Sigurdsson HH, et al. Cross-linked hydroxypropyl-β-cyclodextrin and γ-cyclodextrin nanogels for drug delivery: physicochemical and loading/release properties. Carbohydr Polym 2012;87:2344–51.
   Web of Science ®Google Scholar
• Edsman K, Carlfors J, Petersson R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur J Pharm Sci 1998;6:105–12.
   PubMed Web of Science ®Google Scholar
• Chetoni P, Panichi L, Burgalassi S, et al. Pharmacokinetics and anti-inflammatory activity in rabbits of a novel indomethacin ophthalmic solution. J Ocul Pharmacol Ther 2000;16:363–72.
   PubMed Web of Science ®Google Scholar
• Pepić I, Jalsenjak N, Jalsenjak I. Micellar solutions of triblock copolymer surfactants with pilocarpine. Int J Pharm 2004;272:57–64.
   PubMed Web of Science ®Google Scholar
• El-Kamel AH. In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. Int J Pharm 2002;241:47–55.
   PubMed Web of Science ®Google Scholar
• Kim EY, Gao ZG, Park JS, et al. rhEGF/HP-beta-CD complex in poloxamer gel for ophthalmic delivery. Int J Pharm 2002;233:159–67.
   PubMed Web of Science ®Google Scholar
• Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res 2006;23:2709–28.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Perez AI, Rodriguez-Tenreiro C, Alvarez-Lorenzo C, et al. Drug solubilization and delivery from cyclodextrin-pluronic aggregates. J Nanosci Nanotechnol 2006;6:3179–86.
   PubMed Web of Science ®Google Scholar
• Bonacucina G, Spina M, Misici-Falzi M, et al. Effect of hydroxypropyl beta-cyclodextrin on the self-assembling and thermogelation properties of poloxamer 407. Eur J Pharm Sci 2007;32:115–22.
   PubMed Web of Science ®Google Scholar
• Nogueiras-Nieto L, Alvarez-Lorenzo C, Sandez-Macho I, et al. Hydrosoluble cyclodextrin/poloxamer polypseudorotaxanes at the air/water interface, in bulk solution, and in the gel state. J Phys Chem B 2009;113:2773–82.
   PubMed Web of Science ®Google Scholar
• Wenz G, Han B-H, Müller A. Cyclodextrin rotaxanes and polyrotaxanes. Chem Rev 2006;106:782–817.
   PubMed Web of Science ®Google Scholar
• Lang JC, Stiemke MM. Biological barriers to ocular delivery. In: Reddy IK, ed. Ocular therapeutics and drug delivery. A multidisciplinary approach. Lancaster (PA): Technomics; 1996:51–126.
   Google Scholar
• Chein YW, Cabana BE, Mares SE. Ocular controlled release drug administration. In: Chein YW, ed. Novel drug delivery systems; fundamentals, development concepts, biomedical assessments (drugs and the pharmaceutical sciences). New York: Marcel Dekker; 1982:13–55.
   Google Scholar
• Sieg JW, Triplett JW. Percorneal retention of topically instilled micronized particles. Retention topically micronized. J Pharm Sci 1980;69:863–4.
   PubMed Web of Science ®Google Scholar
• Jansook P, Loftsson T. γCD/HPγD: synergistic solubilization. Int J Pharm 2008;363:217–9.
   PubMed Web of Science ®Google Scholar
• Espuelas MS, Legrand P, Cheron M, et al. Interaction of amphotericin B with polymeric colloids: a spectroscopic study. Colloids Surf B Biointerfaces 1998;11:141–51.
   Web of Science ®Google Scholar
• Espuelas MS, Legrand P, Campanero MA, et al. Polymeric carriers for amphotericin B: in vitro activity, toxicity and therapeutic efficacy against systemic candidiasis in neutropenic mice. J Antimicrob Chemother 2003;52:419–27.
   PubMed Web of Science ®Google Scholar
• González-Gaitano G, Rodríguez P, Isasi JR, et al. The aggregation of cyclodextrins as studied by photon correlation spectroscopy. J Incl Phenom Macrocycl Chem 2002;44:101–5.
   Web of Science ®Google Scholar
• Loftsson T, Hreinsdóttir D, Másson M. Evaluation of cyclodextrin solubilization of drugs. Int J Pharm 2005;302:18–28.
   PubMed Web of Science ®Google Scholar
• Higuchi T, Conners KA. Phase-solubility techniques. Adv Anal Chem Instrum 1965;4:117–212.
   Google Scholar
• Jores K, Mehnert W, Mäder K. Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: a nuclear magnetic resonance and electron spin resonance study. Pharm Res 2003;20:1274–83.
   PubMed Web of Science ®Google Scholar
• Klyamkin AA, Topchieva IN, Zubov VP. Monomolecular films of pluronic cyclodextrin inclusion complexes at the water-gas interface. Colloid Polym Sci 1995;273:520–3.
   Web of Science ®Google Scholar
• Gaitano GG, Brown W, Tardajos G. Inclusion complexes between cyclodextrins and triblock copolymers in aqueous solution: a dynamic and static light-scattering study. J Phys Chem B 1997101:710–19.
   Web of Science ®Google Scholar
• Valero M, Carrillo C, Rodríguez LJ. Ternary naproxen: beta-cyclodextrin:polyethylene glycol complex formation. Int J Pharm 2003;265:141–9.
   PubMed Web of Science ®Google Scholar
• Figueiras A, Nunes SCC, Simões S, et al. Molecular interaction governing solubility and release profiles in supramolecular systems containing fenbufen, pluronics and cyclodextrins. J Incl Phenom Macrocycl Chem 2015;81:395–407.
   Web of Science ®Google Scholar
• Sánchez-Brunete JA, Dea MA, Rama S, et al. Amphotericin B molecular organization as an essential factor to improve activity/toxicity ratio in the treatment of visceral leishmaniasis. J Drug Target 2004;12:453–60.
   PubMed Web of Science ®Google Scholar
• Brewster ME, Loftsson T. Cyclodextrins as pharmaceutical solubilizers. Adv Drug Deliv Rev 2007;59:645–66.
   PubMed Web of Science ®Google Scholar
• Messner M, Kurkov SV, Jansook P, Loftsson T. Self-assembled cyclodextrin aggregates and nanoparticles. Int J Pharm 2010;387:199–208.
   PubMed Web of Science ®Google Scholar
• Jansook P, Ritthidej GC, Ueda H, et al. γCD/HPγCD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension. J Pharm Pharm Sci 2010;13:336–50.
   PubMed Web of Science ®Google Scholar
• Ciba-Geigy. Wissenschaftliche Tabellen Geigy. 8th ed. Basel: Ciba-Geigy; 1977.
   Google Scholar
• Legrand P, Chéron M, Leroy L, Bolard J. Release of amphotericin B from delivery systems and its action against fungal and mammalian cells. J Drug Target 1997;4:311–19.
   PubMed Web of Science ®Google Scholar
• Yu BG, Okano T, Kataoka K, Kwon G. Polymeric micelles for drug delivery: solubilization and haemolytic activity of amphotericin B. J Control Release 1998;53:131–6.
   PubMed Web of Science ®Google Scholar
• Loftsson T, Stefánsdóttir Ó, Friôriksdóttir H, Guômundsson Ö. Interactions between preservatives and 2-hydroxypropyl-β-cyclodextrin. Drug Dev Ind Pharm 1992;18:1477–84.
   Web of Science ®Google Scholar
• Jiao J. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery. Adv Drug Deliv Rev 2008;60:1663–73.
   PubMed Web of Science ®Google Scholar
• Nogueiras-Nieto L, Sobarzo-Sánchez E, Gómez-Amoza JL, Otero-Espinar FJ. Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: implications in drug solubilization and delivery. Eur J Pharm Biopharm 2012;80:585–95.
   PubMed Web of Science ®Google Scholar